4ux6
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
| - | ''' | + | ==The discovery of novel, potent and highly selective inhibitors of inducible nitric oxide synthase (iNOS)== |
| - | + | <StructureSection load='4ux6' size='340' side='right' caption='[[4ux6]], [[Resolution|resolution]] 3.00Å' scene=''> | |
| - | + | == Structural highlights == | |
| - | + | <table><tr><td colspan='2'>[[4ux6]] is a 2 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4UX6 OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4UX6 FirstGlance]. <br> | |
| - | + | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=H4B:5,6,7,8-TETRAHYDROBIOPTERIN'>H4B</scene>, <scene name='pdbligand=HEM:PROTOPORPHYRIN+IX+CONTAINING+FE'>HEM</scene>, <scene name='pdbligand=YWO:O-(5-METHYL-2-NITROPHENYL)-D-TYROSINAMIDE'>YWO</scene></td></tr> | |
| - | + | <tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/Nitric-oxide_synthase_(NADPH_dependent) Nitric-oxide synthase (NADPH dependent)], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=1.14.13.39 1.14.13.39] </span></td></tr> | |
| - | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4ux6 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4ux6 OCA], [http://www.rcsb.org/pdb/explore.do?structureId=4ux6 RCSB], [http://www.ebi.ac.uk/pdbsum/4ux6 PDBsum]</span></td></tr> | |
| + | </table> | ||
| + | __TOC__ | ||
| + | </StructureSection> | ||
| + | [[Category: Andrews, G.]] | ||
| + | [[Category: Beaton, H G.]] | ||
| + | [[Category: Birkinshaw, T.]] | ||
| + | [[Category: Boughton-Smith, N.]] | ||
| + | [[Category: Cheshire, D R.]] | ||
| + | [[Category: Connolly, S.]] | ||
| + | [[Category: Cook, T R.]] | ||
| + | [[Category: Cooper, A.]] | ||
| + | [[Category: Cooper, S L.]] | ||
| + | [[Category: Cox, D.]] | ||
| + | [[Category: Dixon, J.]] | ||
| + | [[Category: Gensmantel, N.]] | ||
| + | [[Category: Hamley, P J.]] | ||
| + | [[Category: Harrison, R.]] | ||
| + | [[Category: Hartopp, P.]] | ||
| + | [[Category: Kack, H.]] | ||
| + | [[Category: Luker, T.]] | ||
| + | [[Category: Mete, A.]] | ||
| + | [[Category: Millichip, I.]] | ||
| + | [[Category: Nicholls, D J.]] | ||
| + | [[Category: Pimm, A D.]] | ||
| + | [[Category: St-Gallay, S A.]] | ||
| + | [[Category: Wallace, A V.]] | ||
| + | [[Category: Drug design]] | ||
| + | [[Category: Oxidoreductase]] | ||
Revision as of 07:58, 8 October 2014
The discovery of novel, potent and highly selective inhibitors of inducible nitric oxide synthase (iNOS)
| |||||||||||
Categories: Andrews, G. | Beaton, H G. | Birkinshaw, T. | Boughton-Smith, N. | Cheshire, D R. | Connolly, S. | Cook, T R. | Cooper, A. | Cooper, S L. | Cox, D. | Dixon, J. | Gensmantel, N. | Hamley, P J. | Harrison, R. | Hartopp, P. | Kack, H. | Luker, T. | Mete, A. | Millichip, I. | Nicholls, D J. | Pimm, A D. | St-Gallay, S A. | Wallace, A V. | Drug design | Oxidoreductase
